Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

19th Jan 2015 13:29

RNS Number : 5282C
GlaxoSmithKline PLC
19 January 2015
 

GlaxoSmithKline plc

 

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities (PDMR) and Connected Persons on 16 January 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1427.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.19 per ADS following the notional re-investment of the dividend paid to shareholders on 8 January 2015.

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

18,634.726

Dr M M Slaoui

5,838.447

Mr S Dingemans

7,826.922

Mr R G Connor

2,559.691

Mrs D P Connelly

2,427.946

Mr N Hirons

314.028

Mr S A Hussain

6,349.257

Mr W C Louv

1,712.688

Mr D S Redfern

2,695.290

Ms C Thomas

3,719.918

Mr P C Thomson

1,814.523

Mr D E Troy

3,469.890

Dr P J T Vallance

7,749.851

Ms E Walmsley

4,505.102

Mrs V A Whyte

515.784

 

 

 

Connected Person

 

Ordinary Shares

 

ADSs

Dr K Slaoui (connected person to Dr M M Slaoui)

88.247

Mrs K Thomson (connected person to Mr P C Thomson)

84.998

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

 

 

 

V A Whyte

Company Secretary

19 January 2015

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXKLFFEFFLBBQ

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77